Description

• Montelukast – Leukotriene Receptor Antagonist:

1. Attenuates Exercise-Induced Bronchoconstriction: Helps prevent bronchoconstriction during exercise in asthma patients.

• Levocetirizine – H1 Receptor Antagonist:

1. Relieves Nasal Symptoms: Improves nasal airflow and provides decongestant activity in patients with asthma.

• Benefits of Combination Therapy over Monotherapy in Allergic Asthma:

1. Improves Symptoms & Lung Function
2. Decreases Acute Exacerbations
3. Reduces Intake of Inhaled Corticosteroids
4. Improves Quality of Life
5. Significantly Decreases Blood Eosinophil Count